| 000 | 02723 a2200757 4500 | ||
|---|---|---|---|
| 005 | 20250514233753.0 | ||
| 264 | 0 | _c20050929 | |
| 008 | 200509s 0 0 eng d | ||
| 022 | _a1522-8002 | ||
| 024 | 7 |
_a10.1593/neo.04655 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFandy, Tamer E | |
| 245 | 0 | 0 |
_aInteractive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma. _h[electronic resource] |
| 260 |
_bNeoplasia (New York, N.Y.) _cJul 2005 |
||
| 300 |
_a646-57 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAmino Acid Chloromethyl Ketones _xpharmacology |
| 650 | 0 | 4 |
_aAnnexin A5 _xpharmacology |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 | _aApoptosis Regulatory Proteins |
| 650 | 0 | 4 |
_aCalpain _xmetabolism |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 |
_aCell Cycle Proteins _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 | _aCyclin-Dependent Kinase Inhibitor p27 |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xmetabolism |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 | _aE2F Transcription Factors |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aG1 Phase |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHistone Deacetylase Inhibitors |
| 650 | 0 | 4 |
_aHistones _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoblotting |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aLeupeptins _xpharmacology |
| 650 | 0 | 4 |
_aLuciferases _xmetabolism |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xmetabolism |
| 650 | 0 | 4 | _aMembrane Potentials |
| 650 | 0 | 4 | _aMicroscopy, Fluorescence |
| 650 | 0 | 4 |
_aMitochondria _xmetabolism |
| 650 | 0 | 4 |
_aMultiple Myeloma _xmetabolism |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aPropidium _xpharmacology |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aRibonucleases _xmetabolism |
| 650 | 0 | 4 |
_aSubcellular Fractions _xmetabolism |
| 650 | 0 | 4 | _aTNF-Related Apoptosis-Inducing Ligand |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTranscription Factors _xmetabolism |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xmetabolism |
| 650 | 0 | 4 | _aUp-Regulation |
| 700 | 1 | _aShankar, Sharmila | |
| 700 | 1 | _aRoss, Douglas D | |
| 700 | 1 | _aSausville, Edward | |
| 700 | 1 | _aSrivastava, Rakesh K | |
| 773 | 0 |
_tNeoplasia (New York, N.Y.) _gvol. 7 _gno. 7 _gp. 646-57 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1593/neo.04655 _zAvailable from publisher's website |
| 999 |
_c15681651 _d15681651 |
||